Sort
39,280 grants matching “leukemia”
Mechanisms and targeting of aberrant Gas activation in myeloid neoplasms
$677,959Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Single-cell Analysis of Normal and Perturbed Dynamic Biological Systems
$677,833Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
BAFF-R CAR T cell therapy for ALL
$677,623Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
BAFF-R CAR T cell therapy for ALL
$677,623Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Lymphoma Studies
$677,573Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer
$677,567Jonathan D. Licht · Northwestern University At Chicago · U54 · FY2018 · CA
Protein-coding and non-coding RNA biomarkers for early detection of CLL
$677,471George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Conformal Total Body and Marrow Irradiation for Leukemia
$677,328Susanta K Hui · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Development of a Phenotype-based Predictive Analytic for Acute Myeloid Leukemia
$677,289Michael R Savona · Vanderbilt University Medical Center · R01 · FY2025 · CA
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
$677,284Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · R01 · FY2009 · CA
Mechanisms of RUNX1 transcriptional control in hematopoiesis
$677,094Kristy Stengel · Albert Einstein College Of Medicine · R01 · FY2025 · HL
Germline and Somatic Genomic Studies in CLL Minorities
$677,092Susan L Slager · Mayo Clinic Rochester · R01 · FY2021 · CA
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
$677,089Cynthia A Gerhardt · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · CA
Improving Informed Consent in Childhood Cancer Trials
$677,084Case Western Reserve University · R01 · FY2003 · CA
Regulation Of Immune Responses In Humans and in Experimental Animals
$676,945Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Cytomegalovirus as an etiologic and clinico-pathogenic factor in childhood acute lymphoblastic leukemia
$676,777Joseph Leo Wiemels · University Of Southern California · R01 · FY2025 · CA
Tumor Microenvironment in Cancer Progression
$676,757Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications
$676,727Kelly Diringer Getz · University Of Pennsylvania · R01 · FY2024 · HL
Brain-Imaging Markers of Neurotoxicity and Long-Term Outcomes after CAR-T Cell Therapy
$676,469Ravi Bansal · Children'S Hospital Of Los Angeles · R01 · FY2024 · CA
Therapy-related leukemia following autologous transplantation for lymphoma
$676,409Smita Bhatia · Beckman Research Institute/City Of Hope · P50 · FY2018 · CA
Chronic Health Conditions in Survivors of Down Syndrome-Associated Leukemia
$676,350Maria Monica Gramatges · Baylor College Of Medicine · R01 · FY2025 · CA
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
$676,096Julie Dunning Hotopp · University Of Maryland Baltimore · R01 · FY2015 · CA
PROMOTING INNATE IMMUNITY AGAINST ACUTE MYELOID LEUKEMIA VIA INHIBITION OF MICA/B SHEDDING
$675,999Icahn School Of Medicine At Mount Sinai · · FY2022 · Department of the Army
Targeted Small Molecule Inhibitors for Inv(16) Leukemia
$675,954John Hackett Bushweller · University Of Virginia · R01 · FY2020 · CA
New tools for quantitative non-invasive recording of biochemical signals
$675,594Nathan Christopher Shaner · University Of California, San Diego · R01 · FY2024 · CA